Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-01-05 @ 5:56 PM
Study NCT ID:
NCT00610857
Status:
COMPLETED
Last Update Posted:
2017-06-22
First Post:
2008-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma
Sponsor:
Ahmad Tarhini
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2015-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-28
First Submit QC Date:
None
Study First Post Date:
2008-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-21
Results First Submit QC Date:
None
Results First Post Date:
2016-10-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-20
Last Update Post Date:
2017-06-22
Last Update Post Date Type:
ACTUAL